Advanced Search


Study ID Status Title Patient Level Data
116236 Completed A two-part, randomised, placebo-controlled study to investigatethe safety, tolerability, pharmacokinetics and pharmacodynamicsof single doses of inhaled GSK1995057 in healthy subjects
116239 Completed An observational cohort study to assess the risk of autoimmune diseases in adolescent and young adult women aged 9 to 25 years exposed to Cervarix® in the United Kingdom
116246 Completed A multicenter, randomized, evaluator-masked, parallel-group, non-treatment-controlled study followed by an open-label study to evaluate efficacy and safety of GSK1358820 (botulinum toxin type A) in patients with strabismus
116265 Active, Not Recruiting PGx432 evaluation of the effect of UGT1A1 polymorphisms on dolutegravir pharmacokinetics: meta-analysis of Phase 1 studies ING111521, ING111603, ING111604, ING112934, ING113068, ING113096, ING114005, ING114819, ING113099
116266 Terminated A Three-Part Phase I, Open-Label, Single Ascending Dose, and A Single-Blind, Placebo-Controlled, Repeat Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Relative Bioavailability of Intravenous and Oral GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects Study Listed on
116268 Completed Comparison of Maraviroc to Efavirenz, Atazanavir, Darunavir, Lopinavir/Ritonavir, and Raltegravir for Treatment-Naïve Persons with CCR5-Positive HIV-1 in Canada
116273 Completed Burden of Influenza in the United Kingdom, 1996-2008
116276 Completed Utilization of Rosiglitazone in Triple Therapy and Insulin Combinations, and Estimated Rates of Adverse Events in Rosiglitazone Recipients in Canada, 2004-2010
116281 Completed Persistence and Compliance among United States patients with advanced Renal Cell Carcinoma receiving treatment with Pazopanib
116287 Recruiting An open label, multi-centre, non-interventional post-marketing surveillance to monitor the safety of KIVEXA(abacavir/lamivudine) administered in Korean patients according to the prescribing information
116288 Completed The effect of dutasteride (0.5 mg/day) on prostate cancer risk reduction using three randomized controlled trials; A set of meta-analyses.
116294 Completed PGx419: Pharmacogenetic Evaluation of Decrease in Left Ventricular Ejection Fraction (LVEF) in Lapatinib Treated Metastatic Breast Cancer (MBC) Subjects
116296 Completed place of Flixovate® in the treatment pathway and its conditions of use in infants aged from 3 to 12 months between 2010 and 2012 by French GPs and private paediatricians
116297 Completed Profile of patients with type 2 diabetes newly treated
116312 Active, Not Recruiting Assessing the rotavirus positive test results in 11 hospitals in Belgium from 2005 to 2013: the RotaBIS study (Rotavirus Belgian Impact Study)
116313 Completed The cost of illness associated with influenza in the United Kingdom
116316 Completed Validation of the new COPD assessment test (CAT) translated into Thai in patients with Chronic Obstructive Pulmonary Disease (COPD)
116317 Completed Sentinel surveillance for influenza requiring hospital admission in Canadian adults
116318 Completed Plan for Re-Evaluation of Sudden Unexplained Death in Epilepsy (SUDEP) Occurring in the Lamotrigine Clinical Development Program
116320 Completed Cost-effectiveness of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome in Canada (OASIS-5) (1)
116329 Completed Optimizing the quality of samples used for the evaluation of cell-mediated immune (CMI) responses in antiretroviral therapy (ART)-naïve Human deficiency virus type 1 (HIV-1)-infected subjects
116343 Completed A Three Part, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of Inhaled and Intravenous GSK2862277 in Healthy Volunteers Study Listed on
116344 Completed PGx471: Combined pharmacogenetic analysis of IL28B genotypes in TPL108390 and TPL103922
116352 Completed Molecular Characterization of Methicillin-Resistant Staphylococcus aureus isolates from the GSK132322 Phase II a Study
116357 Completed Burden of respiratory syncytial virus (RSV) in the United Kingdom, 1995 to 2009



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.